Amicus Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Option
CROWLEY JOHN F director, officer: Chairman & CEO
 Stock Options (right to buy) 142,250 $15.03 $2,137,733
Sale
CROWLEY JOHN F director, officer: Chairman & CEO
 Common Stock 142,250 $15.03 $2,137,733
Option
CROWLEY JOHN F director, officer: Chairman & CEO
 Common Stock 142,250 $15.03 $2,137,733
Sale
VALENZANO KEN officer: SVP, Pharmacology & Bi..
 Common stock 9,500 $5.33 $50,588
Option
CROWLEY JOHN F director, officer: Chairman & CEO
 Common Stock 7,750 $4.16 $32,240
Sale
CROWLEY JOHN F director, officer: Chairman & CEO
 Common Stock 7,750 $4.16 $32,240
Option
CROWLEY JOHN F director, officer: Chairman & CEO
 Stock Options (right to buy) 7,750 $4.16 $32,240
Option
VALENZANO KEN officer: SVP, Pharmacology & Bi..
 Common stock 15,000 $11.78 $176,625
Option
SBLENDORIO GLENN director
 Common stock 10,000 $10.53 $105,300
Option
VALENZANO KEN officer: SVP, Pharmacology & Bi..
 Stock Options (right to buy) 15,000 $11.78 $176,625
Option
SBLENDORIO GLENN director
 Stock Options (right to buy) 10,000 $10.53 $105,300
Sale
SBLENDORIO GLENN director
 Common stock 10,000 $10.53 $105,300
Sale
DOSHI DIPAL officer: SVP Strategy & Bus Dev
 Common stock 6,250 $13.87 $86,688
Option
DOSHI DIPAL officer: SVP Strategy & Bus Dev
 Common stock 12,500 N/A N/A
Sale
QUIMI DAPHNE officer: Chief Financial Officer
 Common stock 2,600 $13.98 $36,351
Option
PEIST KENNETH officer: VP, Legal & IP
 Stock Options (right to buy) 10,000 $4.38 $43,800
Option
PEIST KENNETH officer: VP, Legal & IP
 Common stock 10,000 $4.38 $43,800
Option
GERSHKOWITZ JAYNE officer: SVP, Chief Patient Adv..
 Common stock 10,649 $13.98 $148,820
Option
QUIMI DAPHNE officer: Chief Financial Officer
 Stock Options (right to buy) 2,600 $1.77 $4,589
Option
QUIMI DAPHNE officer: Chief Financial Officer
 Common stock 2,600 $13.98 $36,351
Sale
PEIST KENNETH officer: VP, Legal & IP
 Common stock 10,000 $4.38 $43,800
Sale
GERSHKOWITZ JAYNE officer: SVP, Chief Patient Adv..
 Common stock 10,649 $13.98 $148,820
Option
GERSHKOWITZ JAYNE officer: SVP, Chief Patient Adv..
 Stock Options (right to buy) 10,649 $1.18 $12,534
Option
HAYDEN DONALD J JR director
 Common stock 55,000 $14.01 $770,385
Sale
HAYDEN DONALD J JR director
 Common stock 55,000 $14.01 $770,385
Option
HAYDEN DONALD J JR director
 Stock Options (right to buy) 10,000 $2.81 $28,100
Option
CASTELLI JEFF officer: SVP, Program Management
 Common stock 18,981 $13.94 $264,633
Option
CASTELLI JEFF officer: SVP, Program Management
 Stock Options (right to buy) 18,981 $0.84 $15,944
Option
VALENZANO KEN officer: SVP, Pharmacology & Bi..
 Common stock 20,500 $13.85 $284,007
Sale
VALENZANO KEN officer: SVP, Pharmacology & Bi..
 Common stock 20,500 $13.85 $284,007
Option
VALENZANO KEN officer: SVP, Pharmacology & Bi..
 Stock Options (right to buy) 20,500 $0.83 $17,056
Sale
CASTELLI JEFF officer: SVP, Program Management
 Common stock 18,981 $13.94 $264,633
Option
DILONE ENRIQUE officer: SVP, Technical Operati..
 Common stock 14,045 $13.26 $186,279
Option
CAMPBELL BRADLEY L director, officer: Chief Operat..
 Common stock 13,000 $8.71 $113,256
Sale
BAIRD WILLIAM D III officer: Chief Financial Officer
 Common stock 15,235 $13.26 $202,062
Option
CAMPBELL BRADLEY L director, officer: Chief Operat..
 Stock Options (right to buy) 12,583 $4.16 $52,345
Option
CAMPBELL BRADLEY L director, officer: Chief Operat..
 Common stock 13,000 $8.71 $113,256
Option
CAMPBELL BRADLEY L director, officer: Chief Operat..
 Stocl Options (right to buy) 416 N/A N/A
Sale
CAMPBELL BRADLEY L director, officer: Chief Operat..
 Common stock 13,000 $13.26 $172,419
Sale
DILONE ENRIQUE officer: SVP, Technical Operati..
 Common stock 14,045 $13.26 $186,279
Option
BAIRD WILLIAM D III officer: Chief Financial Officer
 Common stock 15,235 $10.02 $152,624
Option
DILONE ENRIQUE officer: SVP, Technical Operati..
 Stock Options (right to buy) 14,045 $0.83 $11,685
Option
BAIRD WILLIAM D III officer: Chief Financial Officer
 Stock Options (right to buy) 15,235 $10.02 $152,624
Sale
YU JULIE officer: VP Clinical Ops & Data..
 Common stock 8,195 $14.17 $116,123
Sale
CASTELLI JEFF officer: SVP, Program Management
 Common stock 7,377 $14.17 $104,532
Option
CROWLEY JOHN F director, officer: Chairman & CEO
 Common Stock 55,000 $2.81 $154,550
Option
CASTELLI JEFF officer: SVP, Program Management
 Stock Options (right to buy) 17,312 $1.26 $21,813
Option
CASTELLI JEFF officer: SVP, Program Management
 Common stock 17,312 $12.87 $222,805
Option
CROWLEY JOHN F director, officer: Chairman & CEO
 Stock Options (right to buy) 55,000 $2.81 $154,550
Sale
CASTELLI JEFF officer: SVP, Program Management
 Common stock 17,312 $12.87 $222,805

Showing 800 to 850 of 1301 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: